Biktarvy
RxNorm concept 1999668, brand name (bn).
- RxCUI
- 1999668
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1999668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- tenofovir alafenamide fumarate (PIN, has precise ingredient)
- bictegravir sodium (PIN, has precise ingredient)
- bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG [Biktarvy] (SBDC, ingredient of)
- bictegravir / emtricitabine / tenofovir alafenamide Oral Tablet [Biktarvy] (SBDF, ingredient of)
- Biktarvy Oral Product (SBDG, ingredient of)
- Biktarvy Pill (SBDG, ingredient of)
- bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Biktarvy] (SBD, ingredient of)
- bictegravir 30 MG / emtricitabine 120 MG / tenofovir alafenamide 15 MG [Biktarvy] (SBDC, ingredient of)
- bictegravir 30 MG / emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet [Biktarvy] (SBD, ingredient of)
- emtricitabine (IN, tradename of)
- tenofovir alafenamide (IN, tradename of)
- bictegravir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1999668 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1999668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1999668. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.